Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

DAVID R LILJENQUIST

Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism

NPI
1932109931
CMS profile
223086
Location
IDAHO FALLS, ID

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$1,559.39

110 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,559.39 110

By paying entity

PY2022 · entire year · sorted by reported total

Page 3 of 3; records 101–110 of 110 matching records. This page contains 10 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

DAVID R LILJENQUIST

NPI 1932109931 · CMS profile ID 223086

Allopathic & Osteopathic Physicians / Internal Medicine / Endocrinology, Diabetes & Metabolism

IDAHO FALLS, ID

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 3; records 101–110 of 110 matching records. This page contains 10 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1932109931?year=2022&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
DAVID R LILJENQUIST, NPI 1932109931, CMS profile ID 223086. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–110 of 110 matching records. This page contains 10 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1932109931?year=2022&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). DAVID R LILJENQUIST, NPI 1932109931, CMS profile ID 223086. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–110 of 110 matching records. This page contains 10 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1932109931?year=2022&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
DAVID R LILJENQUIST, NPI 1932109931, CMS profile ID 223086, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 3; records 101–110 of 110 matching records. This page contains 10 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1932109931?year=2022&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

110 matching records · $1,559.39 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 110 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–110 of 110.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
SANOFI-AVENTIS U.S. LLC $12.1902/03/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938930391 CMS
Novo Nordisk Inc $7.9902/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 898822003 CMS
Nevro Corp. $15.5301/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 900561961 CMS
Ultragenyx Pharmaceutical Inc. $15.4901/20/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 963732617 CMS
Novartis Pharmaceuticals Corporation $9.0001/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893897939 CMS
Novo Nordisk Inc $6.8801/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 899391177 CMS
Novo Nordisk Inc $1.8001/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 899441653 CMS
Xeris Pharmaceuticals, Inc. $15.3601/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 946474443 CMS
Novartis Pharmaceuticals Corporation $13.1701/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893897935 CMS
SANOFI-AVENTIS U.S. LLC $13.7601/03/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938930385 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $1,492.40 128
PY2020 $1,413.28 92
PY2021 $1,345.14 100
PY2022 $1,559.39 110
PY2023 $1,079.63 71
PY2024 $1,187.67 78
PY2025 $1,125.51 57

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $1,557,392.04 317
PY2024 Principal investigator $2,626,789.75 69
PY2023 Principal investigator $3,253,813.33 127
PY2022 Principal investigator $3,009,072.09 125
PY2021 Principal investigator $1,589,084.64 119
PY2020 Principal investigator $2,095,299.08 111
PY2019 Principal investigator $2,692,883.33 103

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

317 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ABBVIE INC. $5,734.00 12/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH
A Phase 2/3 multicenter, double blinded, randomized, dose-conversion, active control study examining the efficacy and safety of Armour Thyroid compared to synthetic T4 for the treatment of adults with primary hypothyroidism No dispute reported 06/30/2026 1202533887
Principal investigator 1 Sequel Med Tech, LLC $488.00 12/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243755615
Principal investigator 1 Sequel Med Tech, LLC $146.40 12/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243755620
Principal investigator 1 Sequel Med Tech, LLC $488.00 12/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243755626
Principal investigator 1 Sequel Med Tech, LLC $146.40 12/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243755632
Principal investigator 1 Sequel Med Tech, LLC $8,000.00 12/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243755636
Principal investigator 1 Sequel Med Tech, LLC $2,400.00 12/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243755641
Principal investigator 1 Sequel Med Tech, LLC $2,223.00 12/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243755647
Principal investigator 1 Sequel Med Tech, LLC $666.90 12/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243755653
Principal investigator 1 Sequel Med Tech, LLC $488.00 12/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243755657
Principal investigator 1 Sequel Med Tech, LLC $146.40 12/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243755663
Principal investigator 1 Sequel Med Tech, LLC $2,223.00 12/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243755667
Principal investigator 1 Sequel Med Tech, LLC $666.90 12/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243755672
Principal investigator 1 Sequel Med Tech, LLC $488.00 12/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243755677
Principal investigator 1 Sequel Med Tech, LLC $146.40 12/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243755683
Principal investigator 1 Sequel Med Tech, LLC $488.00 12/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243755689
Principal investigator 1 Sequel Med Tech, LLC $146.40 12/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243755695
Principal investigator 1 Sequel Med Tech, LLC $3,200.00 12/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243755703
Principal investigator 1 Sequel Med Tech, LLC $960.00 12/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243755707
Principal investigator 1 Sequel Med Tech, LLC $488.00 12/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243755712
Principal investigator 1 Sequel Med Tech, LLC $146.40 12/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243755719
Principal investigator 1 Sequel Med Tech, LLC $2,223.00 12/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243755724
Principal investigator 1 Sequel Med Tech, LLC $666.90 12/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243755729
Principal investigator 1 Sequel Med Tech, LLC $488.00 12/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243755733
Principal investigator 1 Sequel Med Tech, LLC $146.40 12/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243755740
Principal investigator 1 Sequel Med Tech, LLC $488.00 12/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243755745
Principal investigator 1 Sequel Med Tech, LLC $146.40 12/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243755750
Principal investigator 1 Sequel Med Tech, LLC $488.00 12/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243755754
Principal investigator 1 Sequel Med Tech, LLC $146.40 12/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243755759
Principal investigator 1 Sequel Med Tech, LLC $488.00 12/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243755765
Principal investigator 1 Sequel Med Tech, LLC $146.40 12/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243755771
Principal investigator 1 Sequel Med Tech, LLC $488.00 12/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243755776
Principal investigator 1 Sequel Med Tech, LLC $146.40 12/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243755781
Principal investigator 1 Sequel Med Tech, LLC $488.00 12/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243755787
Principal investigator 1 Sequel Med Tech, LLC $146.40 12/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243755793
Principal investigator 1 Sequel Med Tech, LLC $3,200.00 12/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243755799
Principal investigator 1 Sequel Med Tech, LLC $960.00 12/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243755805
Principal investigator 1 Sequel Med Tech, LLC $488.00 12/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243755810
Principal investigator 1 Sequel Med Tech, LLC $146.40 12/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243755816
Principal investigator 1 Sequel Med Tech, LLC $488.00 12/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243755822
Principal investigator 1 Sequel Med Tech, LLC $146.40 12/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243755828
Principal investigator 1 Sequel Med Tech, LLC $3,200.00 12/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243755831
Principal investigator 1 Sequel Med Tech, LLC $960.00 12/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243755837
Principal investigator 1 SANOFI US SERVICES INC. $1,839.35 12/22/2025 Non-covered Recipient Entity
Rocky Mountain Clinical Research, Llc
A Multicenter, Multinational Extension of Study PRV-031-001 to Evaluate the Long-Term Safety of Teplizumab (PRV-031), a Humanized, FcR Non-Binding, Anti-CD3 Monoclonal Antibody, in Children and Adolescents With Recent-Onset Type 1 Diabetes Mellitus No dispute reported 06/30/2026 1226108258
Principal investigator 1 Abbott Laboratories $183.00 12/17/2025 Non-covered Recipient Entity
Rocky Mountain Clinical Research, LLC
NCT02073058--Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring System No dispute reported 06/30/2026 1248162080
Principal investigator 1 Abbott Laboratories $496.00 12/17/2025 Non-covered Recipient Entity
Rocky Mountain Clinical Research, LLC
NCT02073058--Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring System No dispute reported 06/30/2026 1248162082
Principal investigator 1 Abbott Laboratories $3.10 12/17/2025 Non-covered Recipient Entity
Rocky Mountain Clinical Research, LLC
NCT02073058--Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring System No dispute reported 06/30/2026 1248162084
Principal investigator 1 Abbott Laboratories $72.00 12/17/2025 Non-covered Recipient Entity
Rocky Mountain Clinical Research, LLC
NCT02073058--Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring System No dispute reported 06/30/2026 1248162086
Principal investigator 1 ABBVIE INC. $9,692.48 12/05/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202529382
Principal investigator 1 Sequel Med Tech, LLC $488.00 11/30/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243752369
Principal investigator 1 Sequel Med Tech, LLC $146.40 11/30/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243752374
Principal investigator 1 Sequel Med Tech, LLC $488.00 11/30/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243752379
Principal investigator 1 Sequel Med Tech, LLC $146.40 11/30/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243752386
Principal investigator 1 Sequel Med Tech, LLC $2,223.00 11/30/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243752392
Principal investigator 1 Sequel Med Tech, LLC $666.90 11/30/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243752398
Principal investigator 1 Sequel Med Tech, LLC $488.00 11/30/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243752404
Principal investigator 1 Sequel Med Tech, LLC $146.40 11/30/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243752410
Principal investigator 1 Sequel Med Tech, LLC $488.00 11/30/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243752416
Principal investigator 1 Sequel Med Tech, LLC $146.40 11/30/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243752422
Principal investigator 1 Sequel Med Tech, LLC $488.00 11/30/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243752428
Principal investigator 1 Sequel Med Tech, LLC $146.40 11/30/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243752434
Principal investigator 1 Sequel Med Tech, LLC $3,200.00 11/30/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243752440
Principal investigator 1 Sequel Med Tech, LLC $960.00 11/30/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243752446
Principal investigator 1 Sequel Med Tech, LLC $488.00 11/30/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243752451
Principal investigator 1 Sequel Med Tech, LLC $146.40 11/30/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243752457
Principal investigator 1 Sequel Med Tech, LLC $2,223.00 11/30/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243752463
Principal investigator 1 Sequel Med Tech, LLC $666.90 11/30/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243752469
Principal investigator 1 Sequel Med Tech, LLC $488.00 11/30/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243752475
Principal investigator 1 Sequel Med Tech, LLC $146.40 11/30/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243752481
Principal investigator 1 Sequel Med Tech, LLC $488.00 11/30/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243752487
Principal investigator 1 Sequel Med Tech, LLC $146.40 11/30/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243752493
Principal investigator 1 Abbott Laboratories $434.00 11/20/2025 Non-covered Recipient Entity
Rocky Mountain Clinical Research, LLC
NCT02073058--Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring System No dispute reported 06/30/2026 1248162706
Principal investigator 1 Abbott Laboratories $305.00 11/20/2025 Non-covered Recipient Entity
Rocky Mountain Clinical Research, LLC
NCT02073058--Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring System No dispute reported 06/30/2026 1248162708
Principal investigator 1 Abbott Laboratories $17,038.42 11/13/2025 Non-covered Recipient Entity
Rocky Mountain Clinical Research, LLC
ISM2309001A--Janus 1 No dispute reported 06/30/2026 1248160216
Principal investigator 1 Dexcom, Inc. $22,280.00 11/11/2025 Non-covered Recipient Entity
Rocky Mountain Clinical Research
MULTI-SESSION EVALUATION OF THE INVESTIGATIONAL DEXCOM CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEM IN ADULT PARTICIPANTS No dispute reported 06/30/2026 1250962006
Principal investigator 1 Dexcom, Inc. $3,000.00 11/11/2025 Non-covered Recipient Entity
Rocky Mountain Clinical Research
MULTI-SESSION EVALUATION OF THE INVESTIGATIONAL DEXCOM CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEM IN ADULT PARTICIPANTS No dispute reported 06/30/2026 1250962008
Principal investigator 1 Abbott Laboratories $7,500.00 11/07/2025 Non-covered Recipient Entity
Rocky Mountain Clinical Research, LLC
NCT02073058--Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring System No dispute reported 06/30/2026 1248160214
Principal investigator 1 ABBVIE INC. $32,078.08 11/05/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202521703
Principal investigator 1 Abbott Laboratories $51,611.22 11/04/2025 Non-covered Recipient Entity
Rocky Mountain Clinical Research, LLC
ISM2309001A--Janus 1 No dispute reported 06/30/2026 1248160386
Principal investigator 1 Sequel Med Tech, LLC $488.00 10/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243749257
Principal investigator 1 Sequel Med Tech, LLC $146.40 10/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243749263
Principal investigator 1 Sequel Med Tech, LLC $488.00 10/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243749270
Principal investigator 1 Sequel Med Tech, LLC $146.40 10/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243749276
Principal investigator 1 Sequel Med Tech, LLC $488.00 10/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243749282
Principal investigator 1 Sequel Med Tech, LLC $146.40 10/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243749287
Principal investigator 1 Sequel Med Tech, LLC $488.00 10/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243749292
Principal investigator 1 Sequel Med Tech, LLC $146.40 10/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243749297
Principal investigator 1 Sequel Med Tech, LLC $488.00 10/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243749306
Principal investigator 1 Sequel Med Tech, LLC $146.40 10/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243749310
Principal investigator 1 Sequel Med Tech, LLC $488.00 10/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243749315
Principal investigator 1 Sequel Med Tech, LLC $146.40 10/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243749320
Principal investigator 1 Sequel Med Tech, LLC $3,200.00 10/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243749326
Principal investigator 1 Sequel Med Tech, LLC $960.00 10/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243749331
Principal investigator 1 Sequel Med Tech, LLC $2,223.00 10/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243749336
Principal investigator 1 Sequel Med Tech, LLC $666.90 10/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243749343
Principal investigator 1 Sequel Med Tech, LLC $488.00 10/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243749347
Principal investigator 1 Sequel Med Tech, LLC $146.40 10/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243749355
Principal investigator 1 Sequel Med Tech, LLC $3,200.00 10/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243749359
Principal investigator 1 Sequel Med Tech, LLC $960.00 10/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243749365
Principal investigator 1 Sequel Med Tech, LLC $3,200.00 10/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243749371
Principal investigator 1 Sequel Med Tech, LLC $960.00 10/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243749375
Principal investigator 1 Sequel Med Tech, LLC $488.00 10/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243749383
Principal investigator 1 Sequel Med Tech, LLC $146.40 10/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243749389
Principal investigator 1 Sequel Med Tech, LLC $488.00 10/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243749393
Principal investigator 1 Sequel Med Tech, LLC $146.40 10/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243749399
Principal investigator 1 Sequel Med Tech, LLC $3,200.00 10/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243749404
Principal investigator 1 Sequel Med Tech, LLC $960.00 10/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243749410
Principal investigator 1 Sequel Med Tech, LLC $3,200.00 10/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243749414
Principal investigator 1 Sequel Med Tech, LLC $960.00 10/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243749419
Principal investigator 1 Sequel Med Tech, LLC $488.00 10/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243749426
Principal investigator 1 Sequel Med Tech, LLC $146.40 10/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243749432
Principal investigator 1 Sequel Med Tech, LLC $488.00 10/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243749437
Principal investigator 1 Sequel Med Tech, LLC $146.40 10/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243749443
Principal investigator 1 Sequel Med Tech, LLC $3,200.00 10/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243749451
Principal investigator 1 Sequel Med Tech, LLC $960.00 10/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243749456
Principal investigator 1 Abbott Laboratories $852.48 10/29/2025 Non-covered Recipient Entity
Rocky Mountain Clinical Research, LLC
NCT02073058--Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring System No dispute reported 06/30/2026 1248162322
Principal investigator 1 Abbott Laboratories $218.40 10/29/2025 Non-covered Recipient Entity
Rocky Mountain Clinical Research, LLC
NCT02073058--Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring System No dispute reported 06/30/2026 1248162324
Principal investigator 1 Abbott Laboratories $13.95 10/28/2025 Non-covered Recipient Entity
Rocky Mountain Clinical Research, LLC
NCT02073058--Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring System No dispute reported 06/30/2026 1248162334
Principal investigator 1 Abbott Laboratories $1.40 10/28/2025 Non-covered Recipient Entity
Rocky Mountain Clinical Research, LLC
NCT02073058--Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring System No dispute reported 06/30/2026 1248162336
Principal investigator 1 Abbott Laboratories $13.00 10/21/2025 Non-covered Recipient Entity
Rocky Mountain Clinical Research, LLC
NCT02073058--Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring System No dispute reported 06/30/2026 1248162274
Principal investigator 1 Abbott Laboratories $17.70 10/21/2025 Non-covered Recipient Entity
Rocky Mountain Clinical Research, LLC
NCT02073058--Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring System No dispute reported 06/30/2026 1248162276
Principal investigator 1 Abbott Laboratories $26.25 10/21/2025 Non-covered Recipient Entity
Rocky Mountain Clinical Research, LLC
NCT02073058--Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring System No dispute reported 06/30/2026 1248162308
Principal investigator 1 Abbott Laboratories $9.00 10/21/2025 Non-covered Recipient Entity
Rocky Mountain Clinical Research, LLC
NCT02073058--Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring System No dispute reported 06/30/2026 1248162310
Principal investigator 1 Abbott Laboratories $13.00 10/21/2025 Non-covered Recipient Entity
Rocky Mountain Clinical Research, LLC
NCT02073058--Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring System No dispute reported 06/30/2026 1248162312
Principal investigator 1 Abbott Laboratories $58.50 10/21/2025 Non-covered Recipient Entity
Rocky Mountain Clinical Research, LLC
NCT02073058--Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring System No dispute reported 06/30/2026 1248162314
Principal investigator 1 Abbott Laboratories $211.20 10/21/2025 Non-covered Recipient Entity
Rocky Mountain Clinical Research, LLC
NCT02073058--Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring System No dispute reported 06/30/2026 1248162316
Principal investigator 1 Abbott Laboratories $71.40 10/21/2025 Non-covered Recipient Entity
Rocky Mountain Clinical Research, LLC
NCT02073058--Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring System No dispute reported 06/30/2026 1248162318
Principal investigator 1 Abbott Laboratories $171.30 10/21/2025 Non-covered Recipient Entity
Rocky Mountain Clinical Research, LLC
NCT02073058--Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring System No dispute reported 06/30/2026 1248162320
Principal investigator 1 Abbott Laboratories $17.70 10/21/2025 Non-covered Recipient Entity
Rocky Mountain Clinical Research, LLC
NCT02073058--Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring System No dispute reported 06/30/2026 1248162326
Principal investigator 1 Abbott Laboratories $2,723.66 10/20/2025 Non-covered Recipient Entity
Rocky Mountain Clinical Research, LLC
NCT02073058--Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring System No dispute reported 06/30/2026 1248162300
Principal investigator 1 Abbott Laboratories $320.85 10/20/2025 Non-covered Recipient Entity
Rocky Mountain Clinical Research, LLC
NCT02073058--Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring System No dispute reported 06/30/2026 1248162302
Principal investigator 1 Abbott Laboratories $17.40 10/20/2025 Non-covered Recipient Entity
Rocky Mountain Clinical Research, LLC
NCT02073058--Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring System No dispute reported 06/30/2026 1248162304
Principal investigator 1 Abbott Laboratories $82.50 10/20/2025 Non-covered Recipient Entity
Rocky Mountain Clinical Research, LLC
NCT02073058--Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring System No dispute reported 06/30/2026 1248162306
Principal investigator 1 Abbott Laboratories $7.99 10/20/2025 Non-covered Recipient Entity
Rocky Mountain Clinical Research, LLC
NCT02073058--Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring System No dispute reported 06/30/2026 1248162328
Principal investigator 1 Abbott Laboratories $555.00 10/20/2025 Non-covered Recipient Entity
Rocky Mountain Clinical Research, LLC
NCT02073058--Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring System No dispute reported 06/30/2026 1248162330
Principal investigator 1 Abbott Laboratories $29,999.40 10/20/2025 Non-covered Recipient Entity
Rocky Mountain Clinical Research, LLC
NCT02073058--Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring System No dispute reported 06/30/2026 1248162332
Principal investigator 1 Abbott Laboratories $36.75 10/20/2025 Non-covered Recipient Entity
Rocky Mountain Clinical Research, LLC
NCT02073058--Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring System No dispute reported 06/30/2026 1248162338
Principal investigator 1 Abbott Laboratories $216.00 10/17/2025 Non-covered Recipient Entity
Rocky Mountain Clinical Research, LLC
NCT02073058--Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring System No dispute reported 06/30/2026 1248162278
Principal investigator 1 Abbott Laboratories $222.00 10/17/2025 Non-covered Recipient Entity
Rocky Mountain Clinical Research, LLC
NCT02073058--Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring System No dispute reported 06/30/2026 1248162280
Principal investigator 1 Abbott Laboratories $222.00 10/17/2025 Non-covered Recipient Entity
Rocky Mountain Clinical Research, LLC
NCT02073058--Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring System No dispute reported 06/30/2026 1248162282
Principal investigator 1 Abbott Laboratories $38.00 10/17/2025 Non-covered Recipient Entity
Rocky Mountain Clinical Research, LLC
NCT02073058--Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring System No dispute reported 06/30/2026 1248162284
Principal investigator 1 Abbott Laboratories $610.00 10/17/2025 Non-covered Recipient Entity
Rocky Mountain Clinical Research, LLC
NCT02073058--Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring System No dispute reported 06/30/2026 1248162286
Principal investigator 1 Abbott Laboratories $256.00 10/17/2025 Non-covered Recipient Entity
Rocky Mountain Clinical Research, LLC
NCT02073058--Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring System No dispute reported 06/30/2026 1248162288
Principal investigator 1 Abbott Laboratories $4.65 10/17/2025 Non-covered Recipient Entity
Rocky Mountain Clinical Research, LLC
NCT02073058--Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring System No dispute reported 06/30/2026 1248162290
Principal investigator 1 Abbott Laboratories $492.00 10/17/2025 Non-covered Recipient Entity
Rocky Mountain Clinical Research, LLC
NCT02073058--Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring System No dispute reported 06/30/2026 1248162292
Principal investigator 1 Abbott Laboratories $30.98 10/17/2025 Non-covered Recipient Entity
Rocky Mountain Clinical Research, LLC
NCT02073058--Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring System No dispute reported 06/30/2026 1248162294
Principal investigator 1 Abbott Laboratories $237.00 10/17/2025 Non-covered Recipient Entity
Rocky Mountain Clinical Research, LLC
NCT02073058--Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring System No dispute reported 06/30/2026 1248162296
Principal investigator 1 Abbott Laboratories $960.00 10/17/2025 Non-covered Recipient Entity
Rocky Mountain Clinical Research, LLC
NCT02073058--Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring System No dispute reported 06/30/2026 1248162298
Principal investigator 1 ABBVIE INC. $18,033.92 10/09/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202514471
Principal investigator 1 ABBVIE INC. $414.61 10/07/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202513429
Principal investigator 1 Dexcom, Inc. $3,000.00 10/07/2025 Non-covered Recipient Entity
Rocky Mountain Clinical Research
MULTI-SESSION EVALUATION OF THE INVESTIGATIONAL DEXCOM CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEM IN ADULT PARTICIPANTS No dispute reported 06/30/2026 1250962010
Principal investigator 1 Dexcom, Inc. $48,120.00 10/07/2025 Non-covered Recipient Entity
Rocky Mountain Clinical Research
MULTI-SESSION EVALUATION OF THE INVESTIGATIONAL DEXCOM CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEM IN ADULT PARTICIPANTS No dispute reported 06/30/2026 1250962012
Principal investigator 1 Sequel Med Tech, LLC $2,223.00 09/30/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243747401
Principal investigator 1 Sequel Med Tech, LLC $666.90 09/30/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243747407
Principal investigator 1 Sequel Med Tech, LLC $3,200.00 09/30/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243747417
Principal investigator 1 Sequel Med Tech, LLC $960.00 09/30/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243747422
Principal investigator 1 Sequel Med Tech, LLC $488.00 09/30/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243747426
Principal investigator 1 Sequel Med Tech, LLC $146.40 09/30/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243747433
Principal investigator 1 Sequel Med Tech, LLC $488.00 09/30/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243747439
Principal investigator 1 Sequel Med Tech, LLC $146.40 09/30/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243747444
Principal investigator 1 Sequel Med Tech, LLC $488.00 09/30/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243747450
Principal investigator 1 Sequel Med Tech, LLC $146.40 09/30/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243747456
Principal investigator 1 Sequel Med Tech, LLC $488.00 09/30/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243747463
Principal investigator 1 Sequel Med Tech, LLC $146.40 09/30/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243747469
Principal investigator 1 Sequel Med Tech, LLC $488.00 09/30/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243747476
Principal investigator 1 Sequel Med Tech, LLC $146.40 09/30/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243747481
Principal investigator 1 Sequel Med Tech, LLC $2,223.00 09/30/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243747486
Principal investigator 1 Sequel Med Tech, LLC $666.90 09/30/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243747493
Principal investigator 1 Sequel Med Tech, LLC $3,200.00 09/30/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243747497
Principal investigator 1 Sequel Med Tech, LLC $960.00 09/30/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243747502
Principal investigator 1 Sequel Med Tech, LLC $100.00 09/30/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243747509
Principal investigator 1 Sequel Med Tech, LLC $30.00 09/30/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243747515
Principal investigator 1 Sequel Med Tech, LLC $488.00 09/30/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243747522
Principal investigator 1 Sequel Med Tech, LLC $146.40 09/30/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243747529
Principal investigator 1 ABBVIE INC. $19,718.40 09/04/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202508762
Principal investigator 1 Sequel Med Tech, LLC $488.00 08/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243745807
Principal investigator 1 Sequel Med Tech, LLC $146.40 08/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243745813
Principal investigator 1 Sequel Med Tech, LLC $488.00 08/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243745819
Principal investigator 1 Sequel Med Tech, LLC $146.40 08/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243745825
Principal investigator 1 Sequel Med Tech, LLC $488.00 08/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243745835
Principal investigator 1 Sequel Med Tech, LLC $146.40 08/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243745842
Principal investigator 1 Sequel Med Tech, LLC $3,200.00 08/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243745846
Principal investigator 1 Sequel Med Tech, LLC $960.00 08/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243745853
Principal investigator 1 Sequel Med Tech, LLC $3,200.00 08/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243745859
Principal investigator 1 Sequel Med Tech, LLC $960.00 08/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243745865
Principal investigator 1 Sequel Med Tech, LLC $3,200.00 08/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243745869
Principal investigator 1 Sequel Med Tech, LLC $960.00 08/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243745874
Principal investigator 1 Sequel Med Tech, LLC $3,200.00 08/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243745880
Principal investigator 1 Sequel Med Tech, LLC $960.00 08/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243745886
Principal investigator 1 Sequel Med Tech, LLC $2,223.00 08/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243745897
Principal investigator 1 Sequel Med Tech, LLC $666.90 08/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243745903
Principal investigator 1 Sequel Med Tech, LLC $488.00 08/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243745907
Principal investigator 1 Sequel Med Tech, LLC $146.40 08/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243745912
Principal investigator 1 Sequel Med Tech, LLC $488.00 08/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243745918
Principal investigator 1 Sequel Med Tech, LLC $146.40 08/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243745923
Principal investigator 1 Sequel Med Tech, LLC $3,200.00 08/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243745929
Principal investigator 1 Sequel Med Tech, LLC $960.00 08/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243745935
Principal investigator 1 Dexcom, Inc. $61,000.00 08/26/2025 Non-covered Recipient Entity
Rocky Mountain Clinical Research
MULTI-SESSION EVALUATION OF THE INVESTIGATIONAL DEXCOM CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEM IN ADULT PARTICIPANTS No dispute reported 06/30/2026 1250962004
Principal investigator 1 ABBVIE INC. $27,532.80 08/06/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202503061
Principal investigator 1 Abbott Laboratories $218.40 08/04/2025 Non-covered Recipient Entity
Rocky Mountain Clinical Research, LLC
ISM2309001A--Janus 1 No dispute reported 06/30/2026 1248157756
Principal investigator 1 Abbott Laboratories $852.48 08/04/2025 Non-covered Recipient Entity
Rocky Mountain Clinical Research, LLC
ISM2309001A--Janus 1 No dispute reported 06/30/2026 1248157758
Principal investigator 1 Sequel Med Tech, LLC $2,223.00 07/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243745114
Principal investigator 1 Sequel Med Tech, LLC $666.90 07/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243745119
Principal investigator 1 Sequel Med Tech, LLC $3,200.00 07/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243745125
Principal investigator 1 Sequel Med Tech, LLC $960.00 07/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243745131
Principal investigator 1 Sequel Med Tech, LLC $3,200.00 07/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243745137
Principal investigator 1 Sequel Med Tech, LLC $960.00 07/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243745144
Principal investigator 1 Dexcom, Inc. $8,500.00 07/22/2025 Non-covered Recipient Entity
Rocky Mountain Clinical Research
MULTI-SESSION EVALUATION OF THE INVESTIGATIONAL DEXCOM CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEM IN ADULT PARTICIPANTS No dispute reported 06/30/2026 1250962002
Principal investigator 1 ABBVIE INC. $22,771.20 07/02/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202494023
Principal investigator 1 Sequel Med Tech, LLC $488.00 06/30/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243744395
Principal investigator 1 Sequel Med Tech, LLC $146.40 06/30/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243744401
Principal investigator 1 Sequel Med Tech, LLC $488.00 06/30/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243744405
Principal investigator 1 Sequel Med Tech, LLC $146.40 06/30/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243744412
Principal investigator 1 Sequel Med Tech, LLC $488.00 06/30/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243744418
Principal investigator 1 Sequel Med Tech, LLC $146.40 06/30/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243744424
Principal investigator 1 Sequel Med Tech, LLC $488.00 06/30/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243744429
Principal investigator 1 Sequel Med Tech, LLC $146.40 06/30/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243744435
Principal investigator 1 Sequel Med Tech, LLC $488.00 06/30/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243744440
Principal investigator 1 Sequel Med Tech, LLC $146.40 06/30/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243744445
Principal investigator 1 Sequel Med Tech, LLC $488.00 06/30/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243744451
Principal investigator 1 Sequel Med Tech, LLC $146.40 06/30/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243744457
Principal investigator 1 Sequel Med Tech, LLC $488.00 06/30/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243744461
Principal investigator 1 Sequel Med Tech, LLC $146.40 06/30/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243744468
Principal investigator 1 Sequel Med Tech, LLC $488.00 06/30/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243744474
Principal investigator 1 Sequel Med Tech, LLC $146.40 06/30/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243744478
Principal investigator 1 Sequel Med Tech, LLC $2,223.00 06/30/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243744484
Principal investigator 1 Sequel Med Tech, LLC $666.90 06/30/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243744490
Principal investigator 1 Sequel Med Tech, LLC $2,223.00 06/30/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243744497
Principal investigator 1 Sequel Med Tech, LLC $666.90 06/30/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243744504
Principal investigator 1 ABBVIE INC. $28,336.64 06/03/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202488637
Principal investigator 1 Sequel Med Tech, LLC $8,000.00 05/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243743687
Principal investigator 1 Sequel Med Tech, LLC $2,400.00 05/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243743693
Principal investigator 1 Sequel Med Tech, LLC $3,200.00 05/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243743701
Principal investigator 1 Sequel Med Tech, LLC $960.00 05/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243743707
Principal investigator 1 Sequel Med Tech, LLC $3,200.00 05/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243743714
Principal investigator 1 Sequel Med Tech, LLC $960.00 05/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243743720
Principal investigator 1 Sequel Med Tech, LLC $3,200.00 05/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243743725
Principal investigator 1 Sequel Med Tech, LLC $960.00 05/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243743731
Principal investigator 1 Sequel Med Tech, LLC $488.00 05/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243743737
Principal investigator 1 Sequel Med Tech, LLC $146.40 05/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243743743
Principal investigator 1 Sequel Med Tech, LLC $488.00 05/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243743747
Principal investigator 1 Sequel Med Tech, LLC $146.40 05/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243743753
Principal investigator 1 Sequel Med Tech, LLC $488.00 05/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243743759
Principal investigator 1 Sequel Med Tech, LLC $146.40 05/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243743764
Principal investigator 1 Sequel Med Tech, LLC $488.00 05/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243743769
Principal investigator 1 Sequel Med Tech, LLC $146.40 05/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243743776
Principal investigator 1 Sequel Med Tech, LLC $488.00 05/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243743782
Principal investigator 1 Sequel Med Tech, LLC $146.40 05/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243743788
Principal investigator 1 Sequel Med Tech, LLC $488.00 05/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243743794
Principal investigator 1 Sequel Med Tech, LLC $146.40 05/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243743800
Principal investigator 1 Sequel Med Tech, LLC $488.00 05/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243743806
Principal investigator 1 Sequel Med Tech, LLC $146.40 05/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243743811
Principal investigator 1 ABBVIE INC. $3,525.00 05/28/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202486489
Principal investigator 1 ABBVIE INC. $10,456.32 05/07/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202483181
Principal investigator 1 Dexcom, Inc. $2,500.00 04/22/2025 Non-covered Recipient Entity
Rocky Mountain Clinical Research
MULTI-SESSION FEASIBILITY STUDY OF THE DEXCOM G7 DELTA CONTINUOUS GLUCOSE MONITORING (CGM) SENSOR IN ADULT AND PEDIATRIC SUBJECTS No dispute reported 06/30/2026 1250962000
Principal investigator 1 ABBVIE INC. $2,975.00 04/10/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202475923
Principal investigator 1 ABBVIE INC. $11,802.88 04/03/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202472769
Principal investigator 1 Sequel Med Tech, LLC $4,000.00 03/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243743309
Principal investigator 1 Sequel Med Tech, LLC $1,200.00 03/31/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH LLC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243743313
Principal investigator 1 Abbott Laboratories $852.48 03/12/2025 Non-covered Recipient Entity
Rocky Mountain Clinical Research, LLC
ISM2309001A--Janus 1 No dispute reported 06/30/2026 1248148796
Principal investigator 1 Abbott Laboratories $218.40 03/12/2025 Non-covered Recipient Entity
Rocky Mountain Clinical Research, LLC
ISM2309001A--Janus 1 No dispute reported 06/30/2026 1248148798
Principal investigator 1 ABBVIE INC. $11,215.36 03/07/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH
M21-341 - A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202459414
Principal investigator 1 ABBVIE INC. $600.97 02/13/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH
M21-341 - A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202451308
Principal investigator 1 Dexcom, Inc. $2,500.00 02/11/2025 Non-covered Recipient Entity
Rocky Mountain Clinical Research
MULTI-SESSION FEASIBILITY STUDY OF THE DEXCOM G7 DELTA CONTINUOUS GLUCOSE MONITORING (CGM) SENSOR IN ADULT AND PEDIATRIC SUBJECTS No dispute reported 06/30/2026 1250961998
Principal investigator 1 ABBVIE INC. $6,553.60 02/06/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH
M21-341 - A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202448447
Principal investigator 1 Senseonics, Incorporated $1,584.00 02/06/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH, LLC
Senseonics CTP-0039 No dispute reported 06/30/2026 1249852645
Principal investigator 1 Senseonics, Incorporated $4,333.80 02/06/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH, LLC
Senseonics CTP-0039 No dispute reported 06/30/2026 1249852647
Principal investigator 1 Senseonics, Incorporated $17,961.00 02/06/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH, LLC
Senseonics CTP-0039 No dispute reported 06/30/2026 1249852649
Principal investigator 1 Senseonics, Incorporated $17,831.00 02/06/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH, LLC
Senseonics CTP-0039 No dispute reported 06/30/2026 1249852651
Principal investigator 1 Senseonics, Incorporated $17,831.00 02/06/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH, LLC
Senseonics CTP-0039 No dispute reported 06/30/2026 1249852653
Principal investigator 1 Senseonics, Incorporated $17,831.00 02/06/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH, LLC
Senseonics CTP-0039 No dispute reported 06/30/2026 1249852655
Principal investigator 1 Senseonics, Incorporated $17,831.00 02/06/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH, LLC
Senseonics CTP-0039 No dispute reported 06/30/2026 1249852657
Principal investigator 1 Senseonics, Incorporated $425.00 02/06/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH, LLC
Senseonics CTP-0039 No dispute reported 06/30/2026 1249852659
Principal investigator 1 Senseonics, Incorporated $17,831.00 02/06/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH, LLC
Senseonics CTP-0039 No dispute reported 06/30/2026 1249852661
Principal investigator 1 Senseonics, Incorporated $100.00 02/06/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH, LLC
Senseonics CTP-0039 No dispute reported 06/30/2026 1249852663
Principal investigator 1 Senseonics, Incorporated $17,831.00 02/06/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH, LLC
Senseonics CTP-0039 No dispute reported 06/30/2026 1249852665
Principal investigator 1 Senseonics, Incorporated $13,373.25 02/06/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH, LLC
Senseonics CTP-0039 No dispute reported 06/30/2026 1249852667
Principal investigator 1 Senseonics, Incorporated $17,831.00 02/06/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH, LLC
Senseonics CTP-0039 No dispute reported 06/30/2026 1249852669
Principal investigator 1 Senseonics, Incorporated $200.00 02/06/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH, LLC
Senseonics CTP-0039 No dispute reported 06/30/2026 1249852671
Principal investigator 1 Senseonics, Incorporated $425.00 02/06/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH, LLC
Senseonics CTP-0039 No dispute reported 06/30/2026 1249852673
Principal investigator 1 Senseonics, Incorporated $1,584.00 02/06/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH, LLC
Senseonics CTP-0039 No dispute reported 06/30/2026 1249852675
Principal investigator 1 Senseonics, Incorporated $4,333.80 02/06/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH, LLC
Senseonics CTP-0039 No dispute reported 06/30/2026 1249852677
Principal investigator 1 Senseonics, Incorporated $17,961.00 02/06/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH, LLC
Senseonics CTP-0039 No dispute reported 06/30/2026 1249852679
Principal investigator 1 Senseonics, Incorporated $7,920.00 02/06/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH, LLC
Senseonics CTP-0039 No dispute reported 06/30/2026 1249852681
Principal investigator 1 Senseonics, Incorporated $4,333.80 02/06/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH, LLC
Senseonics CTP-0039 No dispute reported 06/30/2026 1249852683
Principal investigator 1 Senseonics, Incorporated $17,961.00 02/06/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH, LLC
Senseonics CTP-0039 No dispute reported 06/30/2026 1249852685
Principal investigator 1 Senseonics, Incorporated $8,915.50 02/06/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH, LLC
Senseonics CTP-0039 No dispute reported 06/30/2026 1249852687
Principal investigator 1 Senseonics, Incorporated $13,373.25 02/06/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH, LLC
Senseonics CTP-0039 No dispute reported 06/30/2026 1249852689
Principal investigator 1 Senseonics, Incorporated $212.50 02/06/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH, LLC
Senseonics CTP-0039 No dispute reported 06/30/2026 1249852691
Principal investigator 1 Senseonics, Incorporated $1,264.00 02/06/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH, LLC
Senseonics CTP-0039 No dispute reported 06/30/2026 1249852693
Principal investigator 1 Senseonics, Incorporated $17,831.00 02/06/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH, LLC
Senseonics CTP-0039 No dispute reported 06/30/2026 1249852695
Principal investigator 1 Senseonics, Incorporated $100.00 02/06/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH, LLC
Senseonics CTP-0039 No dispute reported 06/30/2026 1249852697
Principal investigator 1 Senseonics, Incorporated $13,373.25 02/06/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH, LLC
Senseonics CTP-0039 No dispute reported 06/30/2026 1249852699
Principal investigator 1 Senseonics, Incorporated $17,831.00 02/06/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH, LLC
Senseonics CTP-0039 No dispute reported 06/30/2026 1249852701
Principal investigator 1 Senseonics, Incorporated $1,062.50 02/06/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH, LLC
Senseonics CTP-0039 No dispute reported 06/30/2026 1249852703
Principal investigator 1 Senseonics, Incorporated $17,831.00 02/06/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH, LLC
Senseonics CTP-0039 No dispute reported 06/30/2026 1249852705
Principal investigator 1 Senseonics, Incorporated $17,831.00 02/06/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH, LLC
Senseonics CTP-0039 No dispute reported 06/30/2026 1249852707
Principal investigator 1 Senseonics, Incorporated $100.00 02/06/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH, LLC
Senseonics CTP-0039 No dispute reported 06/30/2026 1249852709
Principal investigator 1 Senseonics, Incorporated $212.50 02/06/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH, LLC
Senseonics CTP-0039 No dispute reported 06/30/2026 1249852711
Principal investigator 1 Senseonics, Incorporated $3,168.00 02/06/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH, LLC
Senseonics CTP-0039 No dispute reported 06/30/2026 1249852713
Principal investigator 1 Senseonics, Incorporated $17,831.00 02/06/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH, LLC
Senseonics CTP-0039 No dispute reported 06/30/2026 1249852715
Principal investigator 1 Senseonics, Incorporated $17,831.00 02/06/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH, LLC
Senseonics CTP-0039 No dispute reported 06/30/2026 1249852717
Principal investigator 1 Senseonics, Incorporated $17,831.00 02/06/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH, LLC
Senseonics CTP-0039 No dispute reported 06/30/2026 1249852719
Principal investigator 1 Senseonics, Incorporated $635.00 02/06/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH, LLC
Senseonics CTP-0039 No dispute reported 06/30/2026 1249852721
Principal investigator 1 Senseonics, Incorporated $3,612.50 02/06/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH, LLC
Senseonics CTP-0039 No dispute reported 06/30/2026 1249852723
Principal investigator 1 Senseonics, Incorporated $9,706.28 01/16/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH, LLC
Senseonics CTP0039 No dispute reported 06/30/2026 1249852725
Principal investigator 1 Senseonics, Incorporated $120,469.96 01/16/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH, LLC
Senseonics CTP0041 No dispute reported 06/30/2026 1249852727
Principal investigator 1 Senseonics, Incorporated $40,248.42 01/16/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH, LLC
Senseonics CTP0041 No dispute reported 06/30/2026 1249852729
Principal investigator 1 Senseonics, Incorporated $850.00 01/16/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH, LLC
Senseonics CTP0041 No dispute reported 06/30/2026 1249852731
Principal investigator 1 Senseonics, Incorporated $6,336.00 01/16/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH, LLC
Senseonics CTP0041 No dispute reported 06/30/2026 1249852733
Principal investigator 1 Senseonics, Incorporated $36,589.04 01/16/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH, LLC
Senseonics CTP0041 No dispute reported 06/30/2026 1249852735
Principal investigator 1 Senseonics, Incorporated $425.00 01/16/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH, LLC
Senseonics CTP0041 No dispute reported 06/30/2026 1249852737
Principal investigator 1 Senseonics, Incorporated $28,245.28 01/16/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH, LLC
Senseonics CTP0041 No dispute reported 06/30/2026 1249852739
Principal investigator 1 Senseonics, Incorporated $1,487.50 01/16/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH, LLC
Senseonics CTP0041 No dispute reported 06/30/2026 1249852741
Principal investigator 1 Senseonics, Incorporated $55,202.80 01/16/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH, LLC
Senseonics CTP0041 No dispute reported 06/30/2026 1249852743
Principal investigator 1 Senseonics, Incorporated $8,665.88 01/16/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH, LLC
Senseonics CTP0041 No dispute reported 06/30/2026 1249852745
Principal investigator 1 Senseonics, Incorporated $188,556.26 01/16/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN CLINICAL RESEARCH, LLC
Senseonics CTP0041 No dispute reported 06/30/2026 1249852747